ODP531 Worsening of pretibial myxedema following repeated doses of radioiodine treatment in a patient with hyperthyroid Graves’ disease

INTRODUCTION: The development of new-onset pretibial myxedema following radioiodine (RAI) treatment has been occasionally reported from the probable influences of thyrotropin receptor antibodies (TRAbs) similar to the RAI-associated Graves’ ophthalmopathy (GO). However, the worsening of pre-existing...

Descripción completa

Detalles Bibliográficos
Autores principales: Thewjitcharoen, Yotsapon, Chatchomchuan, Waralee, Wanothayaroj, Ekgaluck, Veerasomboonsin, Veekij, Nakasatien, Soontaree, Himathongkam, Thep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627694/
http://dx.doi.org/10.1210/jendso/bvac150.1630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627694/
http://dx.doi.org/10.1210/jendso/bvac150.1630

Ejemplares similares